Pharmaceuticals

Facet-Joint Injection Market Forecast Showing Industry Progress And Growth Trends

April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Facet-Joint Injection Market Progress Between 2026 And 2030?

The market for facet-joint injections has experienced significant expansion recently. This market is projected to expand from $2.97 billion in 2025 to reach $3.18 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.9%. Historically, this growth can be attributed to factors such as the prevalence of spinal degeneration, the incidence of arthritis, increased awareness of pain management techniques, the utilization of corticosteroids, and the rise in outpatient procedures.

The facet-joint injection market size is anticipated to experience robust expansion over the coming years. It is projected to reach $4.1 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This expansion during the forecast period is driven by factors such as an aging population, a preference for minimally invasive treatments, the widespread occurrence of chronic pain, the growth of ambulatory care, and the use of imaging-guided procedures. Key developments expected in this period include an increasing need for minimally invasive pain interventions, greater application in managing chronic back pain, the proliferation of outpatient pain clinics, the adoption of image-guided injection methods, and the broadening of ambulatory surgical centers.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24531&type=smp

What Primary Drivers Are Shaping The Facet-Joint Injection Market?

The increasing occurrence of spinal diseases and persistent back pain is anticipated to fuel the expansion of the facet-joint injection market in the coming years. These conditions encompass long-standing ailments impacting the spine, such as disc degeneration, arthritis, or nerve compression, which result in continuous discomfort, restricted movement, and a diminished quality of life. The surge in spinal diseases and chronic back pain can be attributed to inactive lifestyles and improper posture, prompting individuals to seek efficacious, minimally disruptive treatments to alleviate ongoing discomfort and restore functional movement. Facet-joint injection offers relief for spinal diseases and chronic back pain by diminishing spinal pain and inflammation. For instance, in May 2023, Spinal Cord Inc., a US-based non-profit resource center, reported approximately 18,000 new spinal cord injury (SCI) cases annually in the United States in 2023, with an estimated 302,000 individuals presently living with spinal cord injuries nationwide. Consequently, the growing prevalence of spinal diseases and chronic back pain is a significant factor propelling the facet-joint injection market’s growth.

What Are The Main Segments Within The Facet-Joint Injection Market Segment Structure?

The facet-joint injection market covered in this report is segmented –

1) By Product Type: Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types

2) By Application: Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints

3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users

Subsegments:

1) By Corticosteroids: Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone

2) By Local Anesthetics: Lidocaine, Bupivacaine, Ropivacaine, Prilocaine

3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid

4) By Other Product Types: Platelet-Rich Plasma, Biological Agents, Combination Formulations

What Trends Are Affecting The Growth Of The Facet-Joint Injection Market?

Major companies operating in the facet-joint injection market are concentrating their efforts on developing innovative offerings, such as facet fusion systems, to provide more enduring relief and enhance therapeutic results. Facet fusion systems are defined as medical devices engineered to stabilize and join the spine’s facet joints by encouraging bone development between adjacent vertebrae. As an illustration, in March 2025, Aurora Spine Corporation, a US-based medical device company, announced that the AEROTM Facet Fusion System, its newest product, had secured 510(k) clearance from the U.S. Food and Drug Administration (FDA). This system incorporates a titanium plasma spray coating to boost osseointegration and its capacity for fusion. Furthermore, it supports various implant sizes to suit diverse patient anatomies and includes radiolucent instrumentation to improve visibility during operations. These combined attributes are intended to enhance the effectiveness of procedures and the long-term prognosis for individuals suffering from chronic back pain originating from facet joint disorders.

Who Are The Companies Participating In The Facet-Joint Injection Market?

Major companies operating in the facet-joint injection market are Abbott Laboratories, B. Braun Melsungen AG, BD (Becton Dickinson and Company), Cook Medical, Teleflex Incorporated, Merit Medical Systems Inc., Halyard Health, ICU Medical Inc., Pajunk GmbH Medizintechnologie, Avanos Medical Inc., Vygon SA, Cardinal Health Inc., Terumo Corporation, Nipro Corporation, Septodont Holding, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Piramal Pharma Limited, Intas Pharmaceuticals Ltd., Gland Pharma Limited, Amphastar Pharmaceuticals Inc., Fresenius Medical Care, Baxter International Inc., McKesson Corporation

Get The Full Facet-Joint Injection Market Report:

https://www.thebusinessresearchcompany.com/report/facet-joint-injection-global-market-report

Which Region Is The Leading Market For The Facet-Joint Injection Market?

North America was the largest region in the facet-joint injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facet-joint injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Facet-Joint Injection Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/facet-joint-injection-global-market-report

Browse Through More Reports Similar to the Global Facet-Joint Injection Market 2026, By The Business Research Company

Self Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report

Joint Pain Injections Market Report 2026

https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Facial Injectable Market Report 2026

https://www.thebusinessresearchcompany.com/report/facial-injectable-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795